Regulation of erythropoiesis: emerging concepts and therapeutic implications

References

• Nandakumar SK, Ulirsch JC, Sankaran VG. Advances in understanding erythropoiesis: evolving perspectives. Br J Haematol. 2016;173(2):206–218. DOI:10.1111/bjh.13938
   PubMed Web of Science ®Google Scholar
• Dzierzak E, Philipsen S. Erythropoiesis: development and differentiation. Cold Spring Harb Perspect Med. 2013;3(4):011–601.
   Web of Science ®Google Scholar
• Yumine A, Fraser ST, Sugiyama D. Regulation of the embryonic erythropoietic niche: a future perspective. Blood Res. 2017;52(1):10–17. DOI:10.5045/br.2017.52.1.10
   PubMedGoogle Scholar
• Yamane T. Cellular basis of embryonic hematopoiesis and its implications in prenatal erythropoiesis. Int J Mol Sci. 2020;21(24):9346. DOI:10.3390/ijms21249346
   PubMed Web of Science ®Google Scholar
• Popescu DM, Botting RA, Stephenson E, et al. Decoding human fetal liver haematopoiesis. Nature. 2019;574(7778):365–371. DOI:10.1038/s41586-019-1652-y
   PubMed Web of Science ®Google Scholar
• Palis J. Interaction of the macrophage and primitive erythroid lineages in the mammalian embryo. Front Immunol. 2016;7:669.
   PubMed Web of Science ®Google Scholar
• Baron MH, Vacaru A, Nieves J. Erythroid development in the mammalian embryo. Blood Cells, Molecules, & Diseases. 2013;51(4):213–219. DOI:10.1016/j.bcmd.2013.07.006
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Andrieux G, Kastl P, et al. Erythropoietin-driven dynamic proteome adaptations during erythropoiesis prevent iron overload in the developing embryo. Cell Rep. 2022;40(12):111360. DOI:10.1016/j.celrep.2022.111360
   PubMed Web of Science ®Google Scholar
• Hidalgo D, Bejder J, Pop R, et al. Epor stimulates rapid cycling and larger red cells during mouse and human erythropoiesis. Nat Commun. 2021;12(1):7334. DOI:10.1038/s41467-021-27562-4
   PubMed Web of Science ®Google Scholar
• Barminko J, Reinholt B, Baron MH. Development and differentiation of the erythroid lineage in mammals. Dev Comp Immunol. 2016;58:18–29. DOI:10.1016/j.dci.2015.12.012
   PubMed Web of Science ®Google Scholar
• Eggold JT, Rankin EB. Erythropoiesis, EPO, macrophages, and bone. Bone. 2019;119:36–41. DOI:10.1016/j.bone.2018.03.014
   PubMed Web of Science ®Google Scholar
• Zivot A, Lipton JM, Narla A, et al. Erythropoiesis: insights into pathophysiology and treatments in 2017. Mol Med. 2018;24(1):11–11. DOI:10.1186/s10020-018-0011-z
   PubMedGoogle Scholar
• Iolascon A, Andolfo I, Russo R. Congenital dyserythropoietic anemias. Blood. 2020;136(11):1274–1283. DOI:10.1182/blood.2019000948
   PubMed Web of Science ®Google Scholar
• Valent P, Büsche G, Theurl I, et al. Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment concepts. Haematologica. 2018;103(10):1593–1603. DOI:10.3324/haematol.2018.192518
   PubMed Web of Science ®Google Scholar
• Ramos P, Casu C, Gardenghi S, et al. Macrophages support pathological erythropoiesis in polycythemia vera and beta-thalassemia. Nat Med. 2013;19(4):437–445. DOI:10.1038/nm.3126
   PubMed Web of Science ®Google Scholar
• Caulier AL, Sankaran VG. Molecular and cellular mechanisms that regulate human erythropoiesis. Blood. 2022;139(16):2450–2459. DOI:10.1182/blood.2021011044
   PubMed Web of Science ®Google Scholar
• Le Goff S, Boussaid I, Floquet C, et al. P53 activation during ribosome biogenesis regulates normal erythroid differentiation. Blood. 2021;137(1):89–102. DOI:10.1182/blood.2019003439
   PubMed Web of Science ®Google Scholar
• Gibson JS, Rees DC. Lipid metabolism in terminal erythropoiesis. Blood. 2018;131(26):2872–2874. DOI:10.1182/blood-2018-05-850255
   PubMed Web of Science ®Google Scholar
• Yan H, Ali A, Blanc L, et al. Comprehensive phenotyping of erythropoiesis in human bone marrow: evaluation of normal and ineffective erythropoiesis. Am J Hematol. 2021;96(9):1064–1076. DOI:10.1002/ajh.26247
   PubMed Web of Science ®Google Scholar
• Sun L, Yu Y, Niu B, et al. Red blood cells as potential repositories of MicroRNAs in the circulatory system. Front Genet. 2020;11:442. DOI:10.3389/fgene.2020.00442
   PubMed Web of Science ®Google Scholar
• Parisi S, Finelli C, Fazio A, et al. Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and β-thalassemia. Int J Mol Sci. 2021;22(2):827. DOI:10.3390/ijms22020827
   PubMed Web of Science ®Google Scholar
• Heil J, Olsavszky V, Busch K, et al. Bone marrow sinusoidal endothelium controls terminal erythroid differentiation and reticulocyte maturation. Nat Commun. 2021;12(1):6963. DOI:10.1038/s41467-021-27161-3
   PubMed Web of Science ®Google Scholar
• Tsiftsoglou AS. Erythropoietin (EPO) as a key regulator of erythropoiesis, bone remodeling and endothelial transdifferentiation of multipotent mesenchymal stem cells (MSCs): implications in regenerative medicine. Cells. 2021;10(8):2140. DOI:10.3390/cells10082140
   PubMed Web of Science ®Google Scholar
• Shih H, Wu C, Lin S. Physiology and pathophysiology of renal erythropoietin-producing cells. J Formos Med Assoc. 2018;117(11):955–963. DOI:10.1016/j.jfma.2018.03.017
   PubMed Web of Science ®Google Scholar
• Oikonomidou PR, Rivella S. What can we learn from ineffective erythropoiesis in thalassemia? Blood Rev. 2018;32(2):130–143. DOI:10.1016/j.blre.2017.10.001
   PubMed Web of Science ®Google Scholar
• Kautz L, Nemeth E. Molecular liaisons between erythropoiesis and iron metabolism. Blood. 2014;124(4):479–482. DOI:10.1182/blood-2014-05-516252
   PubMed Web of Science ®Google Scholar
• Shah YM, Xie L. Hypoxia-inducible factors link iron homeostasis and erythropoiesis. Gastroenterology. 2014;146(3):630–642. DOI:10.1053/j.gastro.2013.12.031
   PubMed Web of Science ®Google Scholar
• Zhang A, Enns CA. Grab and go: transferrin uptake in erythropoiesis. Blood. 2022;140(10):1061–1063. DOI:10.1182/blood.2022017638
   PubMed Web of Science ®Google Scholar
• Ginzburg YZ. Chapter two – hepcidin-ferroportin axis in health and disease. In: G Litwack, editor. Vitamins and hormones. Academic Press; 2019. p. 17–45.
   Google Scholar
• Sinha S, Pereira-Reis J, Guerra A, et al. The role of iron in benign and malignant hematopoiesis. Antioxid Redox Signal. 2021;35(6):415–432. DOI:10.1089/ars.2020.8155
   PubMed Web of Science ®Google Scholar
• Chifman J, Laubenbacher R, Torti SV. A systems biology approach to iron metabolism. In: J Chifman, R Laubenbacher, SV Torti, editors. Advances in Experimental Medicine and Biology. New York, NY: Springer New York; 2014. p. 201–225.
   Google Scholar
• Camaschella C, Nai A, Silvestri L. Iron metabolism and iron disorders revisited in the hepcidin era. Haematologica. 2020;105(2):260–272. DOI:10.3324/haematol.2019.232124
   PubMed Web of Science ®Google Scholar
• Wojtaszek E, Glogowski T, Malyszko J. Iron and chronic kidney disease: still a challenge. Front Med (Lausanne). 2020;7:565135. DOI:10.3389/fmed.2020.565135
   PubMed Web of Science ®Google Scholar
• Nemeth E, Ganz T. Hepcidin-ferroportin interaction controls systemic iron homeostasis. Int J Mol Sci. 2021;22(12):6493. DOI:10.3390/ijms22126493
   PubMed Web of Science ®Google Scholar
• Morales M, Xue X. Targeting iron metabolism in cancer therapy. Theranostics. 2021;11(11):8412–8429. DOI:10.7150/thno.59092
   PubMedGoogle Scholar
• Kohgo Y, Niitsu Y, Kondo H, et al. Serum transferrin receptor as a new index of erythropoiesis. Blood. 1987;70(6):1955–1958. DOI:10.1182/blood.V70.6.1955.1955
   PubMed Web of Science ®Google Scholar
• Blanchette NL, Manz DH, Torti FM, et al. Modulation of hepcidin to treat iron deregulation: potential clinical applications. Expert Rev Hematol. 2016;9(2):169–186. DOI:10.1586/17474086.2016.1124757
   PubMed Web of Science ®Google Scholar
• Zhou ZD, Tan EK. Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases. Mol Neurodegener. 2017;12(1):75. DOI:10.1186/s13024-017-0218-4
   PubMedGoogle Scholar
• Ginzburg YZ, Fleming RE. Tfr2 suppression benefits B-thalassemic erythropoiesis. Blood. 2018;132(21):2215–2216. DOI:10.1182/blood-2018-10-876110
   PubMed Web of Science ®Google Scholar
• Kim A, Nemeth E. New insights into iron regulation and erythropoiesis. Curr Opin Hematol. 2015;22(3):199–205. DOI:10.1097/MOH.0000000000000132
   PubMed Web of Science ®Google Scholar
• Pantopoulos K. Tfr2 links iron metabolism and erythropoiesis. Blood. 2015;125(7):1055–1056. DOI:10.1182/blood-2014-12-617571
   PubMed Web of Science ®Google Scholar
• Fujiwara T. GATA transcription factors: basic principles and related human disorders. Tohoku J Exp Med. 2017;242(2):83–91. DOI:10.1620/tjem.242.83
   PubMed Web of Science ®Google Scholar
• Romano O, Petiti L, Felix T, et al. GATA factor-mediated gene regulation in human erythropoiesis. iScience. 2020;23(4):101018. DOI:10.1016/j.isci.2020.101018
   PubMed Web of Science ®Google Scholar
• Barbarani G, Fugazza C, Strouboulis J, et al. The pleiotropic effects of GATA1 and KLF1 in physiological erythropoiesis and in dyserythropoietic disorders. Front Physiol. 2019;10:91. DOI:10.3389/fphys.2019.00091
   PubMed Web of Science ®Google Scholar
• Han X, Zhang J, Peng Y, et al. Unexpected role for p19INK4d in posttranscriptional regulation of GATA1 and modulation of human terminal erythropoiesis. Blood. 2017;129(2):226–237. DOI:10.1182/blood-2016-09-739268
   PubMed Web of Science ®Google Scholar
• Gnanapragasam MN, Bieker JJ. Orchestration of late events in erythropoiesis by KLF1/EKLF. Curr Opin Hematol. 2017;24(3):183–190. DOI:10.1097/MOH.0000000000000327
   PubMed Web of Science ®Google Scholar
• Kim MY, Yan B, Huang S, et al. Regulating the regulators: the role of histone deacetylase 1 (HDAC1) in erythropoiesis. Int J Mol Sci. 2020;21(22):8460. DOI:10.3390/ijms21228460
   PubMed Web of Science ®Google Scholar
• Nakamura K, Smyth MJ. Aberrant erythropoiesis fuels tumor growth. Cell Res. 2018;28(6):611–612. DOI:10.1038/s41422-018-0047-1
   PubMed Web of Science ®Google Scholar
• Villeval J, Vainchenker W. Megakaryocytes tame erythropoiesis with TGFβ1. Blood. 2020;136(9):1016–1017. DOI:10.1182/blood.2020006906
   PubMed Web of Science ®Google Scholar
• Paulson RF, Ruan B, Hao S, et al. Stress erythropoiesis is a key inflammatory response. Cells. 2020;9(3). DOI:10.3390/cells9030634
   PubMed Web of Science ®Google Scholar
• Tomasz G, Ewa W, Jolanta M. Biomarkers of iron metabolism in chronic kidney disease. Int Urol Nephrol. 2021;53(5):935–944. DOI:10.1007/s11255-020-02663-z
   PubMed Web of Science ®Google Scholar
• Chaparro CM, Suchdev PS. Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries. Ann N Y Acad Sci. 2019;1450(1):15–31.
   PubMed Web of Science ®Google Scholar
• Sankaran VG, Weiss MJ. Anemia: progress in molecular mechanisms and therapies. Nat Med. 2015;21(3):221–230. DOI:10.1038/nm.3814
   PubMed Web of Science ®Google Scholar
• Dulmovits BM, Blanc L. Stress erythropoiesis: selenium to the rescue!. Blood. 2018;131(23):2512–2513. DOI:10.1182/blood-2018-04-844720
   PubMed Web of Science ®Google Scholar
• Hellstrom-Lindberg E, Tobiasson M, Greenberg P. Myelodysplastic syndromes: moving towards personalized management. Haematologica. 2020;105(7):1765–1779. DOI:10.3324/haematol.2020.248955
   PubMed Web of Science ®Google Scholar
• Malcovati L, Stevenson K, Papaemmanuil E, et al. SF3B1-mutant MDS as a distinct disease subtype: a proposal from the international working group for the prognosis of MDS. Blood. 2020;136(2):157–170. DOI:10.1182/blood.2020004850
   PubMed Web of Science ®Google Scholar
• Obeng EA, Chappell R, Seiler M, et al. Physiologic expression of SF3B1K700E causes impaired erythropoiesis, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation. Cancer Cell. 2016;30(3):404–417. DOI:10.1016/j.ccell.2016.08.006
   PubMed Web of Science ®Google Scholar
• Wojchowski DM. Ineffective erythropoiesis of TET2 deficiency. Blood. 2018;132(22):2320–2321. DOI:10.1182/blood-2018-10-878645
   PubMed Web of Science ®Google Scholar
• Schoettler ML, Nathan DG. The pathophysiology of acquired aplastic anemia: current concepts revisited. Hematol Oncol Clin North Am. 2018;32(4):581–594. DOI:10.1016/j.hoc.2018.03.001
   PubMed Web of Science ®Google Scholar
• NS Y. Aplastic anemia. N Engl J Med. 2018;17(379):1643–1656.
   Google Scholar
• Bacigalupo A, Passweg J. Diagnosis and treatment of acquired aplastic anemia. Hematol Oncol Clin North Am. 2009;23(2):159–170. DOI:10.1016/j.hoc.2009.01.005
   PubMed Web of Science ®Google Scholar
• Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019 ;133(1):40–50. DOI:10.1182/blood-2018-06-856500
   PubMed Web of Science ®Google Scholar
• Fraenkel PG. Anemia of inflammation: a review. Med Clin N Am. 2017;101(2):285–296. DOI:10.1016/j.mcna.2016.09.005
   PubMed Web of Science ®Google Scholar
• Abdel-Razeq H, Hashem H. Recent update in the pathogenesis and treatment of chemotherapy and cancer induced anemia. Crit Rev Oncol Hematol. 2020;145:102837. DOI:10.1016/j.critrevonc.2019.102837
   PubMed Web of Science ®Google Scholar
• Cazzola M. Introduction to a How I treat series on anemia. Blood. 2020.
   Google Scholar
• Hanna RM, Streja E, Kalantar-Zadeh K. Burden of anemia in chronic kidney disease: beyond erythropoietin. Adv Ther. 2021;38(1):52–75. DOI:10.1007/s12325-020-01524-6
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Russo R, Andolfo I, et al. Inherited microcytic anemias. Hematology. 2020;2020(1):465–470. DOI:10.1182/hematology.2020000158
   PubMedGoogle Scholar
• Newhall DA, Oliver R, Lugthart S. Anaemia: a disease or symptom. Neth J Med. 2020;3(78):104–110.
   Google Scholar
• Dumarchey A, Lavazec C, Verdier F. Erythropoiesis and malaria, a multifaceted interplay. Int J Mol Sci. 2022;23(21):12762. DOI:10.3390/ijms232112762
   PubMed Web of Science ®Google Scholar
• Musallam KM, Bou-Fakhredin R, Cappellini MD, et al. 2021 update on clinical trials in β-thalassemia. Am J Hematol. 2021;96(11):1518–1531. DOI:10.1002/ajh.26316
   PubMed Web of Science ®Google Scholar
• Munkongdee T, Chen P, Winichagoon P, et al. Update in laboratory diagnosis of thalassemia. Front Mol Biosci. 2020;7:74–74. DOI:10.3389/fmolb.2020.00074
   PubMed Web of Science ®Google Scholar
• Motta I, Bou-Fakhredin R, Taher AT, et al. Beta thalassemia: new therapeutic options beyond transfusion and iron chelation. Drugs (New York, NY). 2020;80(11):1053–1063.
   Google Scholar
• Mithoowani S, Laureano M, Crowther MA, et al. Investigation and management of erythrocytosis. CMAJ. 2020;192(32):913–918. DOI:10.1503/cmaj.191587
   PubMed Web of Science ®Google Scholar
• Alzoubi B, Kharel A, Machhi R, et al. Post-transplant erythrocytosis after kidney transplantation: a review. World J Transplant. 2021;11(6):220–230. DOI:10.5500/wjt.v11.i6.220
   PubMedGoogle Scholar
• McMullin MFF, Mead AJ, Ali S, et al. A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: a British society for haematology guideline. Br J Haematol. 2019;184(2):161–175. DOI:10.1111/bjh.15647
   PubMed Web of Science ®Google Scholar
• Gaspersic J, Kristan A, Kunej T, et al. Erythrocytosis: genes and pathways involved in disease development. Blood Transfus. 2021;19(6):518–532.
   PubMedGoogle Scholar
• Cazzola M, Cazzola M. Introduction to a review series on normal and pathologic erythropoiesis. Blood. 2022;139(16):2413–2414. DOI:10.1182/blood.2022015497
   PubMed Web of Science ®Google Scholar
• Spivak JL. How I treat polycythemia vera. Blood. 2019;4(134):345–352.
   Google Scholar
• Mende N, Bastos HP, Santoro A, et al. Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans. Blood. 2022;139(23):3387–3401. DOI:10.1182/blood.2021013450
   PubMed Web of Science ®Google Scholar
• Haldar M. Stressed about erythropoiesis: EBI macrophages. Blood. 2018;132(24):2530–2532. DOI:10.1182/blood-2018-10-882183
   PubMed Web of Science ®Google Scholar
• Ulyanova T, Phelps SR, Papayannopoulou T. The macrophage contribution to stress erythropoiesis: when less is enough. Blood. 2016;128(13):1756–1765. DOI:10.1182/blood-2016-05-714527
   PubMed Web of Science ®Google Scholar